This intricate interplay between KPNA2 and the FOXM1-CCNB1/B2 axis not only provides insights into breast cancer cell cycle regulation but also suggests potential therapeutic targets in breast cancer treatment. This evidence concerns the gene CCNB1 and breast carcinoma.